nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0511	0.0654	CbGpPWpGaD
Pirenzepine—CHRM5—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0436	0.0558	CbGpPWpGaD
Pirenzepine—CHRM5—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0423	0.0542	CbGpPWpGaD
Pirenzepine—CHRM5—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0394	0.0504	CbGpPWpGaD
Pirenzepine—CHRM5—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0367	0.0469	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.036	0.0461	CbGpPWpGaD
Pirenzepine—CHRM5—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0356	0.0455	CbGpPWpGaD
Pirenzepine—CHRM5—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0332	0.0424	CbGpPWpGaD
Pirenzepine—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0307	0.0393	CbGpPWpGaD
Pirenzepine—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0298	0.0381	CbGpPWpGaD
Pirenzepine—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0278	0.0355	CbGpPWpGaD
Pirenzepine—CHRM5—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0276	0.0353	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0258	0.033	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0251	0.0321	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0233	0.0299	CbGpPWpGaD
Pirenzepine—CHRM5—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0232	0.0297	CbGpPWpGaD
Pirenzepine—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0195	0.0249	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0164	0.0209	CbGpPWpGaD
Pirenzepine—Mirtazapine—DRD4—Gilles de la Tourette syndrome	0.0149	0.0684	CrCbGaD
Pirenzepine—Olanzapine—DRD4—Gilles de la Tourette syndrome	0.014	0.0642	CrCbGaD
Pirenzepine—Acetophenazine—DRD2—Gilles de la Tourette syndrome	0.0139	0.0636	CrCbGaD
Pirenzepine—Mirtazapine—DRD3—Gilles de la Tourette syndrome	0.0129	0.059	CrCbGaD
Pirenzepine—Olanzapine—DRD3—Gilles de la Tourette syndrome	0.0121	0.0554	CrCbGaD
Pirenzepine—Mirtazapine—SLC6A3—Gilles de la Tourette syndrome	0.012	0.0549	CrCbGaD
Pirenzepine—Prochlorperazine—DRD3—Gilles de la Tourette syndrome	0.0105	0.0479	CrCbGaD
Pirenzepine—Mirtazapine—DRD2—Gilles de la Tourette syndrome	0.0089	0.0408	CrCbGaD
Pirenzepine—Loxapine—DRD4—Gilles de la Tourette syndrome	0.00871	0.0399	CrCbGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00842	0.0108	CbGpPWpGaD
Pirenzepine—Olanzapine—DRD2—Gilles de la Tourette syndrome	0.00836	0.0383	CrCbGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00817	0.0105	CbGpPWpGaD
Pirenzepine—Thioproperazine—DRD2—Gilles de la Tourette syndrome	0.00769	0.0353	CrCbGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00761	0.00974	CbGpPWpGaD
Pirenzepine—Thiothixene—DRD2—Gilles de la Tourette syndrome	0.00757	0.0347	CrCbGaD
Pirenzepine—Loxapine—DRD3—Gilles de la Tourette syndrome	0.00751	0.0344	CrCbGaD
Pirenzepine—Clozapine—DRD4—Gilles de la Tourette syndrome	0.00731	0.0335	CrCbGaD
Pirenzepine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00724	0.00926	CbGpPWpGaD
Pirenzepine—Prochlorperazine—DRD2—Gilles de la Tourette syndrome	0.00723	0.0332	CrCbGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00721	0.00922	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00703	0.00899	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.007	0.00895	CbGpPWpGaD
Pirenzepine—Loxapine—SLC6A3—Gilles de la Tourette syndrome	0.00699	0.032	CrCbGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0069	0.00882	CbGpPWpGaD
Pirenzepine—Mirtazapine—HTR2A—Gilles de la Tourette syndrome	0.00688	0.0315	CrCbGaD
Pirenzepine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00655	0.00837	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00652	0.00834	CbGpPWpGaD
Pirenzepine—Olanzapine—HTR2A—Gilles de la Tourette syndrome	0.00646	0.0296	CrCbGaD
Pirenzepine—Clozapine—DRD3—Gilles de la Tourette syndrome	0.00631	0.0289	CrCbGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00617	0.00789	CbGpPWpGaD
Pirenzepine—Thioproperazine—HTR2A—Gilles de la Tourette syndrome	0.00595	0.0273	CrCbGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00593	0.00758	CbGpPWpGaD
Pirenzepine—Thiothixene—HTR2A—Gilles de la Tourette syndrome	0.00585	0.0268	CrCbGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00575	0.00736	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00549	0.00702	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00536	0.00686	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00533	0.00682	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00533	0.00682	CbGpPWpGaD
Pirenzepine—Trifluoperazine—DRD2—Gilles de la Tourette syndrome	0.00523	0.024	CrCbGaD
Pirenzepine—Loxapine—DRD2—Gilles de la Tourette syndrome	0.0052	0.0238	CrCbGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00508	0.00649	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00497	0.00635	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00493	0.0063	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00486	0.00621	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00459	0.00587	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00457	0.00584	CbGpPWpGaD
Pirenzepine—Clozapine—DRD2—Gilles de la Tourette syndrome	0.00436	0.02	CrCbGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00434	0.00556	CbGpPWpGaD
Pirenzepine—Trifluoperazine—HTR2A—Gilles de la Tourette syndrome	0.00404	0.0185	CrCbGaD
Pirenzepine—Loxapine—HTR2A—Gilles de la Tourette syndrome	0.00402	0.0184	CrCbGaD
Pirenzepine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00387	0.00495	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00375	0.0048	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00375	0.0048	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0035	0.00447	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00348	0.00445	CbGpPWpGaD
Pirenzepine—Clozapine—HTR2A—Gilles de la Tourette syndrome	0.00337	0.0155	CrCbGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00322	0.00411	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0031	0.00397	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00301	0.00385	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00282	0.0036	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00281	0.00359	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00274	0.0035	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00255	0.00326	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00245	0.00313	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00219	0.00279	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00212	0.00271	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00198	0.00254	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00198	0.00253	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00197	0.00251	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00193	0.00246	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00179	0.0023	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00179	0.00228	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00166	0.00213	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00162	0.00207	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00151	0.00193	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00138	0.00177	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00126	0.00161	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00117	0.0015	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00114	0.00146	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00106	0.00136	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00105	0.00135	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000743	0.00095	CbGpPWpGaD
